{'fraction_non_alphanumeric': 0.0404648705758056, 'fraction_numerical': 0.025409403063919703, 'mean_word_length': 5.0890961724027015, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Functional Performance After Complex Endovascular Aortic Repair: A Single-Center Retrospective Cohort Study

Purpose Complex endovascular aortic repair (EVAR) procedures provide a treatment option for patients with aortic aneurysms involving visceral branches. Good technical results and short-term outcomes have been reported. Whether complex EVAR provides acceptable functional outcomes is not clear. The current study aims to describe postoperative functional outcomes in complex EVAR patients—an older and relatively frail patient group. Materials and Methods A single-center retrospective cohort study was performed, using data from a computerized database of consecutive patients who underwent complex EVAR in the Leiden University Medical Center (LUMC, The Netherlands) between July 2013 and September 2020. As of May 2017, patients scheduled for complex EVAR were referred to a geriatric care pathway to determine (Instrumental) Activities of Daily Living ((I)ADL) scores at baseline and, if informed consent was given, after 12 months. For the total patient group, adverse functional performance outcomes were: discharge to a nursing home and 12-month mortality. For the patients included in geriatric follow-up, the additional outcome was the incidence of functional decline (defined by a ≥2 point increase in (I)ADL-score) at 12-month follow-up Results Eighty-two patients underwent complex EVAR, of which 68 (82.9%) were male. Mean age was 73.3 years (SD=6.3). Within 30 days postsurgery, 6 patients (7.3%) died. Mortality within 12 months for the total patient group was 14.6% (n=12). After surgery, no patients had to be discharged to a nursing home. Fifteen patients (18.3%) were discharged to a rehabilitation center. Twenty-three patients gave informed consent and were included in geriatric follow-up. Five patients (21.7%) presented functional decline 12 months postsurgery and 4 patients had died (17.4%) by that time. This means that 39.1% of the patients in the care pathway suffered an adverse outcome. Conclusion To our knowledge, this is the only study that examined functional performance after complex EVAR, using a prospectively maintained database. No patients were newly discharged to a nursing home and functional performance results at 12 months are promising. Future multidisciplinary research should focus on determining which patients are most prone to deterioration of function, so that efforts can be directed toward preventing postoperative functional decline.


Introduction
Endovascular aortic repair (EVAR) is well established in clinical practice for treating abdominal aortic aneurysms (AAA) located below the visceral arteries. 1,2 Because of low immediate morbidity and mortality rates compared with open surgical repair (OSR), EVAR is often the procedure of choice. 3,4 In recent years, endovascular techniques for aortic repair have developed extensively. Fenestrated EVAR (FEVAR) and branched EVAR (BEVAR) allow for endovascular treatment of complex aortic aneurysms, comprising segments of the entire aortoiliac tract, including the arch. 5 These techniques have greatly expanded treatment options. Patients with complex aortic aneurysms who are considered too frail for OSR because of (cardiopulmonary) comorbidities, decreased physical performance or other factors increasing the risk of adverse outcomes, can now also be operated using a less invasive endovascular approach. These extensive EVAR procedures have a higher morbidity and mortality risk than conventional infrarenal EVAR. Thirty-day mortality rates ranging from 3.4% up to 8.6% have been reported in complex EVAR, compared with an average of 1.2% in conventional EVAR. [6][7][8][9] Besides morbidity and mortality, patients undergoing complex EVAR are at risk of decline in functional performance. Living independently of care and maintaining quality of life are highly valued outcomes, especially in older patients. [10][11][12] While high technical success rates are commonly reported, evidence on functional performance after complex EVAR is scarce. 13,14 Information on postoperative functional performance is important in order to properly inform patients about the consequences of treatment. We evaluated the functional outcome of patients undergoing complex EVAR in a tertiary referral center. To our knowledge, this study is the only study that examined functional performance after complex EVAR, using a prospectively maintained database.

Study Design and Setting
A single-center retrospective cohort study was performed, using data from a prospectively maintained secure computerized database of consecutive patients who underwent complex EVAR in the Leiden University Medical Center, a tertiary referral center (LUMC, The Netherlands). Patients were included since the introduction of complex EVAR in this hospital in July 2013, until September 2020. The database was approved by the LUMC Medical Ethics Committee (METC). Any information not provided by this database was subtracted from patients' medical records. As in the standard care pathway, all patients were seen at 6 weeks, 6 months, and 12 months postsurgery and yearly after that for outpatient-based follow-up. Additional appointments were made if deemed necessary. Computed tomography angiography, duplex ultrasonography, and abdominal X-ray were used in follow-up. Given the retrospective character of the current study, the METC waived the necessity for informed consent.
As of May 2017, all patients scheduled for complex EVAR were referred to the LUMC geriatric department to undergo a comprehensive geriatric assessment. No selection based on patient demographics was made. This included (Instrumental) Activities of Daily Living Scores ((I)ADL), the 6-item Cognitive Impairment Test (6-CIT), and a Mini Nutritional Assessment (MNA). If the patient gave informed consent for follow-up, they were included in the Triage of Elderly Needing Treatment (TENT) study (ID number: NL53575.058.15). 15 For these patients, geriatric scores were gathered again at 12 months postsurgery, by phone. In the current study, (I)ADL-scores were used to examine functional performance at 12 months.

Patients and Procedures
Complex EVAR was defined as endovascular aortic surgery that entailed correction of an aneurysm including the visceral segment, with or without thoracic involvement. Baseline characteristics were described by demographics, living status, aneurysm characteristics, comorbidities, risk factors, and exercise tolerance by the estimated metabolic equivalent of task (MET) score. 16 (I)ADL-scores were measured by the Katz Index of Independence in Activities of Daily Living (Katz ADL) and the Lawton Instrumental Activities of Daily Living Scale (Lawton IADL). 17,18 The Katz ADL measures the (in)dependency of patients with regard to 6 daily life activities: bathing, getting dressed, toileting, transfers, continence, and feeding. For each activity, patients can score 0 (fully independent) to 2 (dependent). Patients are categorized on a hierarchic 0 to 12 scale, with 0 being independent and 12 being fully dependent in all 6 activities. The Lawton IADL measures the (in)dependency of patients with regard to 8 more complex activities: using the phone, shopping, preparing food, housekeeping, doing laundry, mode of transportation, responsibility for personal medication, and handling finances. Patients are categorized on a 0 to 24 scale, scoring 0 (fully independent) to 3 (not capable/has never performed) per category. The 6-CIT and MNA were used to examine cognitive impairment (score >7) and malnutrition risk (score <11), respectively. [19][20][21] Both the Katz ADL and Lawton IADL are of sufficient validity when conducted by phone. 22,23 Outcomes Adverse outcome measures for the total patient group were postoperative discharge to a nursing home and mortality at 12 months postsurgery. Clinical outcomes were: 30-day mortality, length of hospital stay, and major surgical complications defined as complications with a Clavien-Dindo score of III-IV. 24 For the 23 complex EVAR patients included in the TENT-study, the additional adverse outcome was the incidence of functional decline at 12 months postsurgery. This was defined as an increase of at least 2 points on the Katz ADL and/or Lawton IADL scale. This entails the patient becoming (more) dependent in at least one category and is in line with definitions of functional decline used in other fields. [25][26][27]

Statistical Methods
Baseline characteristics were expressed by number of patients and percentages, or as mean with the standard deviation (SD) in case of normal distribution. In case of skewed distribution, characteristics were presented as median with the interquartile range (Q1, Q3). Patients who did give informed consent for geriatric follow-up were compared with patients who did not consent, based on baseline characteristics. The independent t test was used for continuous normally distributed data, chi-square test for categorical data, and the Mann-Whitney U test for skewed data. All analyses were made using IBM SPSS Statistics version 26.

Patient Characteristics
A total of 82 consecutive patients who underwent complex EVAR were included. Figure 1 shows a flowchart of patient inclusion. Table 1 shows the baseline characteristics of these patients; 68 (82.9%) were male, with a mean age of 73.3 years (SD=6.3). Mean aneurysm size was 65.1 mm (SD=11.1) and 17 patients (20.7%) had undergone previous aortic repair surgery (open or endovascular). Most patients (n=77, 93.9%) were hospitalized from home. Three patients (3.7%) were living in a nursing home, 1 patient (1.2%) lived in a homeless shelter and 1 patient (1.2%) had an unknown living situation at admission. The median ADL baseline score was 0.0 (IQR=0.0, 0.0) and the median IADL score was 1.0 (IQR=0.0, 3.75). Aneurysms were treated using FEVAR (59.8%), BEVAR (25.6%), FBEVAR (11.0%, using a graft with fenestrations and branches) and Arch-FEVAR (3.7%). Figure 2 shows the living status at admission and the destination of discharge after hospital stay. At discharge, 60 patients (73.2%) were able to return to their preadmission living status, either with or without (additional) home care. Fifteen patients (18.3%) admitted from home, were discharged to a rehabilitation center, which was intended to be temporary. One patient (1.2%) previously living in a nursing home was discharged to a rehabilitation center. It is unknown whether this patient was more care dependent at discharge. No complex EVAR patients were newly admitted to a nursing home postsurgery.

Functional Performance
Twenty-three out of the 55 complex EVAR patients referred for geriatric assessment gave informed consent for followup and were included in the TENT-study for a functional performance analysis (Figure 1).
There was no significant difference between the baseline geriatric scores of patients that did give informed consent for follow-up and patients who did not give consent. Patients who did give informed consent were significantly older compared with patients who did not consent to follow-up (75.6 vs 71.8, p=0.027). Baseline geriatric scores of the 23 patients included in follow-up are depicted in Table 2. The median preoperative ADL score of these 23 patients was 0.0 (IQR=0.0, 1.0). The median preoperative IADL-score was 1.0 (IQR=0.0, 4.0). The MNA showed that 3 patients (13.0%) were at risk for malnutrition. Cognitive impairment, measured by the 6-CIT, was present in 1 out of 23 patients (4.3%). Functional outcomes are depicted in Figure  3. At 12 months, 5 patients presented with functional decline (21.7%), 3 patients with IADL decline only, and 2 patients with IADL as well as ADL decline. ADL decline was mainly caused by the need for assistance in bathing and getting dressed (n=2). IADL decline was mostly caused by needing assistance in shopping (n=3). Mortality at 12 months was 17.4% (n=4). This means that 39.1% of the patients in the care pathway suffered an adverse outcome at 12 months postsurgery.
Medical records of the 5 patients who presented (I)ADL decline were searched for postoperative adverse events that could have caused their functional decline. In 1 patient, a preexistent cognitive disorder worsened during follow-up. No potential function-limiting major complications were registered for this patient. In 2 patients, major complications following complex EVAR were reported: spinal ischemia (n=1) and arterial occlusion of the lower limb (n=1). For 2 patients, no adverse events were registered during follow-up, while no function-limiting major complications of complex EVAR were registered to have occurred.

Perioperative Outcomes and Complications
Perioperative outcomes are depicted in Table 3. Twenty-four complications with a Clavien-Dindo score of III-IV were registered, which meant that surgical, laparoscopic, or radiological intervention was necessary or a life-threatening complication took place during hospital stay. These 24 complications occurred in 19 patients (23.2%), including 2 out of the 5 patients who presented functional decline. Median length of hospital stay was 7.0 days (IQR=4.5, 12.5). Median length of follow-up was 21.5 months (IQR=4.1, 42.9). Complications that occurred during follow-up are presented in Table 4. Complications were detected in 33 patients (40.2%); the most common complication was aneurysm sac enlargement (n=19, 23.2%). In 11 patients (13.4%), 17 surgical reinterventions were necessary for complications during follow-up, including 1 out of the 5 patients that suffered functional decline. In addition, 12 patients (14.6%) needed endoleak repair.

Discussion
No patients were discharged to a nursing home and mortality rates were 7.3% and 14.6% at 30 days and 12 months, respectively, for the total patient group. Major adverse  events occurred in 23.2% of patients. Patients included in the TENT-study suffered functional decline at 12 months postsurgery in 21.7% (n=5) and 12-month mortality was 17.4%. The value of these results is difficult to interpret because of the lack of data on functional performance after complex EVAR. We can however compare these results with functional performance after conventional EVAR and OSR. Rectenwald et al 28 showed that 79.5% of patients who underwent OSR for a thoracoabdominal aneurysm was discharged to home or a rehabilitation facility (91.5% in our study), whereas 20.5% (0% in our study) was newly discharged to a nursing home. Arko et al 29 reported that 21% of EVAR patients and 25% of OSR patients were not able to shop/travel at the same level prior to surgery at 6-month follow-up. In addition, 4% of OSR patients lost the ability to independently bathe/eat at the same level compared with presurgery. 29 These results approximate the 21.7% of patients with functional decline at 12 months in our patient cohort. Williamson et al 30 studied patients who underwent OSR for an infrarenal aneurysm, and reported a decrease in 33% of patients in their functional abilities, including transportation and shopping at a mean follow-up of 34 months. Blomaard et al 31 showed that 46.2% of patients acutely hospitalized for internal medicine was either deceased of functionally declined 12 months later. For patients considered frail, this percentage was 67.0%.
By including all 82 consecutive patients that underwent complex EVAR, it was attempted to present an unselected "real-world" patient group, commensurate with patients seen in a daily clinical practice. The 30-day mortality rate found in the current study (7.3%) is higher compared with the mortality rate found by Van Calster et al 32 (4.9%) and lower compared with the 30-day mortality rates mentioned by Oderich et al 6 (8.2%) and Tran et al 7 (8.6%). The difference with Van Calster et al 32 could be explained by different procedures being included. A relatively low percentage of patients was treated for extensive aneurysms using BEVAR (9.2% vs. 25.6% in our study) and no patients were treated using Arch-FEVAR (3.7% in the current study). The use of differing definitions of "complex" EVAR should be kept in mind when interpreting results in the available literature.
This study has several limitations. The number of patients that could be included in the (I)ADL analysis (n=23) is small. However, to our knowledge, this study is the only study that examined functional performance after complex EVAR, using a prospectively maintained database. 33 Another limitation is formed by potential confounders for functional decline during follow-up, such as adverse events not related to the complex EVAR procedure and aging. Although a fixed (I)ADL decline per year of aging is not established in the available literature, we cannot ignore that with increasing age, functional performance declines. 34,35 By confining follow-up to 12 months, we attempted to limit the influence of aging as a confounding factor. Possible confounding adverse events were reported descriptively for the functionally declined patients. Surprisingly, some patients improved in function ( Figure  3). Given the fact that patients electively treated for aortic aneurysms are usually asymptomatic prior to surgery, this is remarkable. One explanation could be that follow-up (I) ADL scores were self-reported, which could lead to an overestimation bias. 36,37  It could also be that with treatment of the aneurysm other function-limiting conditions, such as claudication caused by iliac stenosis, improved. In addition, medication use, nutrition, or postoperative home care might have been optimized during hospital stay. This was not further examined in the current study.
When comparing functional performance after conventional EVAR, OSR, and hospitalized older patients in other fields, complex EVAR results are promising. Even more so considering the general frailty of complex EVAR patients, which makes this group often not suitable for OSR. However, for some patients, the prospect of losing independence or not being able to return home after surgery is unacceptable and can be reason to renounce treatment. [10][11][12] Therefore, multidisciplinary efforts should be directed toward preventing postoperative functional decline and care dependency.

Conclusions
The results found in this study give insight in functional performance after complex EVAR. No patients were newly discharged to a nursing home and functional performance results at 12 months are promising. To our knowledge, this is the only study examining functional performance after complex EVAR, by providing data from a prospectively maintained database. Future multidisciplinary research should focus on determining which patients are most prone to deterioration in function, to support treatment decisions and to optimize patient selection, so that efforts can be directed toward preventing postoperative functional decline.